Debut Plus

39.8

-2.05 -4.90%

As of 10 Sept 2026 · delayed

NSE Listed

Saroja Pharma Industries India Ltd. (SAROJA)

Volume: 12,800Avg Vol 1W: 3,520Avg Vol 1M: 5,28052W Range:2848
Key Ratios
Checked 5h ago
Market Cap₹16 Cr
Current Price₹39.8
Previous Close₹41.85
High / Low (52w)₹48 / ₹28
Volume12,800
Avg Vol (1W)3,520
Avg Vol (1M)5,280
Stock P/E9.9
Book Value₹43.01
Dividend Yield
ROE
ROA
Revenue (TTM)₹54 Cr
Revenue Growth
Profit Margin
Total Debt
Shares Outstanding
Face Value
EPS (TTM)₹4.02
P/B0.93
Debt / Equity0.5
50 DMA₹33.15
200 DMA₹36.74
Day change-4.90%
Price Chart
39.8 15.41% · 1Y
482826K
2025-09-12
2026-09-10

20-day avg volume: 5K shares

Pros
  • Company is almost debt-free.
  • Stock trades below its book value.
Cons
  • Revenue fell 34% YoY.
Profit & Loss (Annual)
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹37 Cr₹56 Cr₹50 Cr₹41 Cr₹54 Cr
EBITDA₹1 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr
Net Profit₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr
EPS2.693.963.612.492.57
Balance Sheet
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹8 Cr₹16 Cr₹21 Cr₹27 Cr₹40 Cr
Total Liabilities₹7 Cr₹11 Cr₹16 Cr₹12 Cr₹24 Cr
Equity₹1 Cr₹4 Cr₹5 Cr₹15 Cr₹16 Cr
Total Debt
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹-1 Cr₹-3 Cr₹3 Cr₹1 Cr₹2 Cr
Investing₹0 Cr₹0 Cr₹-5 Cr₹-5 Cr₹-3 Cr
Financing₹1 Cr₹4 Cr₹3 Cr₹4 Cr₹2 Cr
Free Cash Flow₹-1 Cr₹-3 Cr₹3 Cr₹1 Cr₹2 Cr
Shareholding
Promoter 73.02% Institutions 0% Public 26.98%
Efficiency & Working Capital
ROCE12.6%
Interest Coverage2
Dividend Payout
Debtor Days181 d
Inventory Days1 d
Payable Days93 d
Cash Conversion Cycle89 d
Working Capital Days181 d
Shareholding Details

As of 2026-03-31

Promoter73%
FII0%
DII0%
Institutions0%
Public27%
Promoter Pledge0%
No. of Shareholders413
Shareholding Pattern

Quarterly — figures in %. Latest 6 quarters.

PeriodSept 2023Mar 2024Sept 2024Mar 2025Sept 2025Mar 2026
Promoters73%73%73%73%73%73%
FIIs0%0%0%0%0%0%
DIIs0%0%0%0%0%0%
Public27%27%27%27%27%27%
Promoter Pledge0%0%0%0%0%0%
No. of Shareholders597506438422435413
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Biju Gopinathan NairShareholding of Promoter and Promoter Group72.1%28,96,672
Swastika Investmart LtdPublic Shareholding2%80,000
Kamlesh Natwarlal ShahPublic Shareholding1.3%52,800
Manish Dasharath KambleShareholding of Promoter and Promoter Group1%39,000
Sushama Dasharath KambleShareholding of Promoter and Promoter Group0%2
Aditri Biju NairShareholding of Promoter and Promoter Group0%2
Pulinattu Damodaran NandakumarShareholding of Promoter and Promoter Group0%2
Rethi Krishnan NairShareholding of Promoter and Promoter Group0%2
Bindu Ramachandran KurupShareholding of Promoter and Promoter Group0%2
Sonal Siddarth DiwadkarShareholding of Promoter and Promoter Group0%2
Saroja NairShareholding of Promoter and Promoter Group0%2
Board of Directors
NameDesignationYear
Biju Gopinathan NairChairman & Managing Director2025
Manish Dasharath KambleWhole Time Director & CFO2025
Pulinattu Damodaran NandakumarNon-Exec & Non-Independent Dir2025
Sonal JainIndependent Non Exe. Director2025
Anita SethiaIndependent Non Exe. Director2025
Nikita KumarCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Chemicals like Thionyl Chloride And₹0 Cr
Segments — Geography
RegionRevenueShare
INDIA₹49 Cr91.5%
ASIA PACIFIC₹5 Cr8.5%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10544
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000101
2025000101
2025000101
Company Information
Incorporated2019
ChairmanBiju Gopinathan Nair
AuditorPravin Chandak & Associates
Investor Email[email protected]
🌐 www.sarojapharma.com

📍 305 Kailash Tower Shiv Shristi, Complex Goregaon Link Rd Mum-W, Mumbai, Maharashtra, 400080

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search